CLINICAL_TRIALS
trial_result
· 2015-11-20
Clinical Trial Update: Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
A Phase 2 trial evaluating the combination of ofatumumab and high-dose methylprednisolone in patients with chronic lymphocytic leukemia has completed and posted…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Januario Castro, M.D. | Conditions: CLL | Phase 2 | Status: COMPLETED | Results posted: 2015-11-20